NRx Pharmaceuticals, Inc.
NRXP
$2.75
$0.124.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.91M | 5.55M | 1.44M | 1.65M | 1.90M |
| Total Receivables | -- | -- | -- | 6.00K | 6.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 919.00K | 1.02M | 2.89M | 1.61M | 2.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 761.00K | 693.00K | 824.00K | 848.00K | 830.00K |
| Total Current Assets | 4.59M | 7.26M | 3.30M | 4.11M | 4.88M |
|
|
|||||
| Total Current Assets | 4.59M | 7.26M | 3.30M | 4.11M | 4.88M |
| Net Property, Plant & Equipment | 8.00K | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 240.00K | 334.00K | 349.00K | 356.00K | 384.00K |
| Total Assets | 4.84M | 7.59M | 3.65M | 4.46M | 5.26M |
|
|
|||||
| Total Accounts Payable | 3.63M | 4.31M | 4.13M | 4.87M | 5.02M |
| Total Accrued Expenses | 5.99M | 5.48M | 16.98M | 5.77M | 7.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.85M | 8.40M | 1.25M | 3.05M | 7.65M |
| Total Finance Division Other Current Liabilities | 20.98M | 14.57M | 15.99M | 6.62M | 3.83M |
| Total Other Current Liabilities | 20.98M | 14.57M | 15.99M | 6.62M | 3.83M |
| Total Current Liabilities | 40.45M | 32.75M | 21.86M | 20.30M | 23.66M |
|
|
|||||
| Total Current Liabilities | 40.45M | 32.75M | 21.86M | 20.30M | 23.66M |
| Long-Term Debt | -- | -- | 5.01M | 2.99M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 40.45M | 32.75M | 26.87M | 23.28M | 23.66M |
|
|
|||||
| Common Stock & APIC | 265.75M | 258.62M | 255.05M | 250.37M | 249.18M |
| Retained Earnings | -301.37M | -283.79M | -278.27M | -269.20M | -267.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -3.00K |
| Total Common Equity | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M |
|
|
|||||